Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 79, Issue 11

Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease No Access

Abstract

We examined the antibody responses and protection to a human rotavirus (HRV) in gnotobiotic (Gn) pigs. Pigs were perorally (PO) inoculated with attenuated (group 1), virulent (group 2), or inactivated (group 3) Wa (P1 A [8]G1) HRV. A fourth group was inoculated intramuscularly (IM) with inactivated Wa HRV in adjuvant. After PO challenge with virulent Wa HRV at post-inoculation day 21, most group 1, 3 and 4 pigs shed virus and developed diarrhoea, whereas this occurred in only a few group two pigs. Antibodies to HRV (IgM, IgA or IgG) were detected in serum and intestinal contents of pigs of all groups after virus inoculation or challenge, and the antibody titres in intestinal contents, although lower, showed similar kinetics to the serum responses. There was no correlation between protection and neutralizing antibody titres of serum or intestinal contents, but a positive correlation existed between protection and serum IgA, intestinal IgA and intestinal IgG antibody titres. These findings suggest that serum IgA antibodies to HRV could act as an indicator of IgA antibodies in the intestine after rotavirus infection. The virulent HRV elicited protective immunity and higher levels of serum and intestinal IgA antibodies to HRV compared to attenuated and inactivated HRV. These findings suggest that more efficient mucosal delivery systems and/or adjuvants are needed to enhance the intestinal immune responses to attenuated or inactivated HRV if more successful vaccination is to be achieved in neonates.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-11-2661
1998-11-01
2026-02-14

Metrics

Loading full text...

Full text loading...

References

  1. Kapikian AZ, Chanock RM. Rotaviruses. In Fields BN, Knipe DM. eds In Fields Virology, 2nd edn. New York: Raven Press; 1990 pp 1353–1404
     [Google Scholar]
  2. Hoshino Y, Kapikian AZ. Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children. Trends Microbiol 1994; 2:242–249 [View Article] [PubMed]
     [Google Scholar]
  3. Pérez-Schael I, Guntiñas MJ, Pérez M, Pagone V, Rojas AM et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997; 337:1181–1187 [View Article] [PubMed]
     [Google Scholar]
  4. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME et al. Safety and efficacy of high-dose rhesus-human reassortant Rotavirus vaccines—report of the national multicenter trial. Pediatrics 1996; 98:A38 [View Article]
     [Google Scholar]
  5. Rennels MB, Wasserman SS, Glass RI, Keane VA. Comparison of immunogenicity and efficacy of rhesus Rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine efficacy group. Pediatrics 1995; 96:1132–1136 [PubMed]
     [Google Scholar]
  6. Vesikari T. Clinical trials of live oral Rotavirus vaccines: the finnish experience. Vaccine 1993; 11:255–261 [View Article] [PubMed]
     [Google Scholar]
  7. Desselberger U. Prospects for vaccines against Rotaviruses. Rev Med Virol 1998; 8:43–52 [View Article] [PubMed]
     [Google Scholar]
  8. Johansen K, Granqvist L, Karlén K, Stintzing G, Uhnoo I et al. Serum IgA immune response to individual rotavirus polypeptides in young children with Rotavirus infection. Arch Virol 1994; 138:247–259 [View Article] [PubMed]
     [Google Scholar]
  9. Rennels MB. Rotavirus vaccine comes of age. J Pediatr 1997; 131:512–513 [PubMed]
     [Google Scholar]
  10. Vesikari T. Rotavirus vaccines against diarrhoeal disease. Lancet 1997; 350:1538–1541 [View Article] [PubMed]
     [Google Scholar]
  11. Offit PA. Immunologic determinants of protection against rotavirus disease. Curr Top Microbiol Immunol 1994; 185:229–254 [View Article] [PubMed]
     [Google Scholar]
  12. Davidson GP, Barnes GL. Structural and functional abnormalities of the small intestine in infants and young children with Rotavirus enteritis. Acta Paediatr Scand 1979; 68:181–186 [View Article] [PubMed]
     [Google Scholar]
  13. Coulson BS, Grimwood K, Hudson IL, Barnes GL, Bishop RF. Role of coproantibody in clinical protection of children during reinfection with Rotavirus. J Clin Microbiol 1992; 30:1678–1684 [View Article] [PubMed]
     [Google Scholar]
  14. Offit PA, Clark HF. Protection against Rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol 1985; 54:58–64 [View Article] [PubMed]
     [Google Scholar]
  15. Saif LJ, Jackwood DJ. Enteric virus vaccines: theoretical considerations, current status, and future approaches. In Saif LJ, Theil KW. eds In Viral Diarrheas of Man and Animals Boca Raton, FL: CRC Press; 1990 pp 313–329
     [Google Scholar]
  16. Saif LJ, Ward LA, Yuan L, Rosen BI, To TL. The gnotobiotic pig as a model for studies of disease pathogenesis and immunity to human Rotaviruses. Arch Virol 1996; 12:153–161
     [Google Scholar]
  17. Saif LJ, Yuan L, Ward L, To T. Comparative studies of the pathogenesis, antibody immune responses and homologous protection to porcine and human Rotaviruses in gnotobiotic piglets. In Paul P, Frances D, Benfield D. eds In Mechanisms in the Pathogenesis of Enteric Diseases New York: Plenum Press; 1997 pp 397–403
     [Google Scholar]
  18. Snodgrass DR, Wells PW. Passive immunity in rotaviral infections. J Am Vet Med Assoc 1978; 173:565–568 [PubMed]
     [Google Scholar]
  19. Conner ME, Matson DO, Estes MK. Rotavirus vaccines and vaccination potential. In Ramig RF. eds In Rotaviruses New York: Springer-Verlag; 1994 pp 285–338
     [Google Scholar]
  20. Yuan L, Ward LA, Rosen BI, To TL, Saif LJ. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol 1996; 70:3075–3083 [View Article] [PubMed]
     [Google Scholar]
  21. Yuan L, Kang S-Y, Ward LA, To TL, Saif LJ. Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human Rotavirus. J Virol 1998; 72:330–338 [View Article] [PubMed]
     [Google Scholar]
  22. Conner ME, Gilger MA, Estes MK, Graham DY. Serologic and mucosal immune response to Rotavirus infection in the rabbit model. J Virol 1991; 65:2562–2571 [View Article] [PubMed]
     [Google Scholar]
  23. Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK et al. Identification of group A Rotavirus genes associated with virulence of a porcine Rotavirus and host range restriction of a human Rotavirus in the gnotobiotic piglet model. Virology 1995; 209:274–280 [View Article] [PubMed]
     [Google Scholar]
  24. Mebus CA, Wyatt RG, Kapikian AZ. Intestinal lesions induced in gnotobiotic calves by the virus of human infantile gastroenteritis. Vet Pathol 1977; 14:273–282 [View Article] [PubMed]
     [Google Scholar]
  25. Ramig RF. The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice. Microb Pathog 1988; 4:189–202 [View Article] [PubMed]
     [Google Scholar]
  26. Schaller JP, Saif LJ, Cordle CT, Candler E, Winship TR et al. Prevention of human Rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. J Infect Dis 1992; 165:623–630 [View Article] [PubMed]
     [Google Scholar]
  27. Ward LA, Rosen BI, Yuan L, Saif LJ. Pathogenesis of an attenuated and a virulent strain of group A human Rotavirus in neonatal gnotobiotic pigs. J Gen Virol 1996 b; 77 (Pt 7):1431–1441 [View Article] [PubMed]
     [Google Scholar]
  28. Wyatt RG, Mebus CA, Yolken RH, Kalica AR, James HD Jr et al. Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. Science 1979; 203:548–550 [View Article] [PubMed]
     [Google Scholar]
  29. Wyatt RG, James WD, Bohl EH, Theil KW, Saif LJ et al. Human rotavirus type 2: cultivation in vitro. Science 1980; 207:189–191 [View Article] [PubMed]
     [Google Scholar]
  30. Chen WK, Campbell T, VanCott J, Saif LJ. Enumeration of isotype-specific antibody-secreting cells derived from gnotobiotic piglets inoculated with porcine Rotaviruses. Vet Immunol Immunopathol 1995; 45:265–284 [View Article] [PubMed]
     [Google Scholar]
  31. Ward LA, Yuan L, Rosen BI, Tô TL, Saif LJ. Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig model. Clin Diagn Lab Immunol 1996 a; 3:342–350 [View Article] [PubMed]
     [Google Scholar]
  32. Coffin SE, Klinek M, Offit PA. Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with Rotavirus. J Infect Dis 1995; 172:874–878 [View Article] [PubMed]
     [Google Scholar]
  33. Conner ME, Crawford SE, Barone C, Estes MK. Rotavirus vaccine administered parenterally induces protective immunity. J Virol 1993; 67:6633–6641 [View Article] [PubMed]
     [Google Scholar]
  34. McNeal MM, Sheridan JF, Ward RL. Active protection against Rotavirus infection of mice following intraperitoneal immunization. Virology 1992; 191:150–157 [View Article] [PubMed]
     [Google Scholar]
  35. Bohl EH, Theil KW, Saif LJ. Isolation and serotyping of porcine Rotavirus strains and antigenic comparison with other Rotavirus strains. J Clin Microbiol 1984; 19:105–111 [View Article] [PubMed]
     [Google Scholar]
  36. Fernandez FM, Conner ME, Parwani AV, Todhunter D, Smith KL et al. Isotype-specific antibody responses to Rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP). Vaccine 1996; 14:1303–1312 [View Article] [PubMed]
     [Google Scholar]
  37. Meyer RC, Bohl EH, Kohler EM. Procurement and maintenance of germ-free seine for microbiological investigations. Appl Microbiol 1964; 12:295–300 [View Article] [PubMed]
     [Google Scholar]
  38. Graham DY, Dufour GR, Estes MK. Minimal infective dose of Rotavirus. Arch Virol 1987; 92:261–271 [View Article] [PubMed]
     [Google Scholar]
  39. Saif LJ, Redman DR, Smith KL, Theil KW. Passive immunity to bovine Rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows. Infect Immun 1983; 41:1118–1131 [View Article] [PubMed]
     [Google Scholar]
  40. Kang S-Y, Saif LJ, Miller KL. Reactivity of VP4-specific monoclonal antibodies to a serotype 4 porcine Rotavirus with distinct serotypes of human (symptomatic and asymptomatic) and animal Rotavirus strains. J Clin Microbiol 1989; 27:2744–2750 [View Article] [PubMed]
     [Google Scholar]
  41. Paul PS, Mengeling WL, Malstrom CE, Van Deusen RA. Production and characterization of monoclonal antibodies to porcine immunoglobulin gamma, alpha, and light chains. Am J Vet Res 1989; 50:471–479 [PubMed]
     [Google Scholar]
  42. VanCott JL, Brim TA, Lunney JK, Saif LJ. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J Immunol 1994; 152:3980–3990 [View Article] [PubMed]
     [Google Scholar]
  43. Bernstein DI, Sander DS, Smith VE, Schiff GM, Ward RL. Protection from Rotavirus reinfection: 2-year prospective study. J Infect Dis 1991; 164:277–283 [View Article] [PubMed]
     [Google Scholar]
  44. Matson DO, O’Ryan ML, Herrera I, Pickering LK, Estes MK. Fecal antibody responses to symptomatic and asymptomatic Rotavirus infections. J Infect Dis 1993; 167:577–583 [View Article] [PubMed]
     [Google Scholar]
  45. Ward RL, Bernstein DI. Protection against Rotavirus disease after natural rotavirus infection. J Infect Dis 1994; 169:900–904 [View Article]
     [Google Scholar]
  46. Burns JW, Krishnaney AA, Vo PT, Rouse RV, Anderson LJ et al. Analyses of homologous Rotavirus infection in the mouse model. Virology 1995; 207:143–153 [View Article] [PubMed]
     [Google Scholar]
  47. Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T et al. Protective effect of naturally acquired homotypic and heterotypic Rotavirus antibodies. Lancet 1986; 2:417–421 [View Article] [PubMed]
     [Google Scholar]
  48. Feng N, Burns JW, Bracy L, Greenberg HB. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous Rotavirus. J Virol 1994; 68:7766–7773 [View Article] [PubMed]
     [Google Scholar]
  49. Hjelt K, Grauballe PC, Schiotz PO, Andersen L, Krasilnikoff PA. Intestinal and serum immune response to a naturally acquired rotavirus gastroenteritis in children. J Pediatr Gastroenterol 1985; 4:60–66
     [Google Scholar]
  50. McNeal MM, Broome RL, Ward RL. Active immunity against Rotavirus infection in mice is correlated with viral replication and titers of serum Rotavirus IgA following vaccination. Virology 1994; 204:642–650 [View Article] [PubMed]
     [Google Scholar]
  51. Coulson BS, Grimwood K, Masendycz PJ, Lund JS, Mermelstein N et al. Comparison of rotavirus immunoglobulin A coproconversion with other indices of Rotavirus infection in a longitudinal study in childhood. J Clin Microbiol 1990; 28:1367–1374 [View Article] [PubMed]
     [Google Scholar]
  52. Kapikian AZ, Hoshino Y, Flores J, Midthun K, Glass RI et al. Alternative approaches to the development of a rotavirus vaccine. In Holmgren J, Lindberg A, Mollby R. eds In Development of Vaccines and Drugs Against Diarrhea (11th Nobel Conference) Stockholm, Sweden): Student Literature AB; 1986 pp 192–214
     [Google Scholar]
  53. Ward RL, McNeal MM, Sheridan JF. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 1992; 188:57–66 [View Article] [PubMed]
     [Google Scholar]
  54. Woode GN, Zheng SL, Rosen BI, Knight N, Gourley NE et al. Protection between different serotypes of bovine Rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses. J Clin Microbiol 1987; 25:1052–1058 [View Article] [PubMed]
     [Google Scholar]
  55. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of Rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996; 272:104–107 [View Article] [PubMed]
     [Google Scholar]
  56. Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB et al. Protection against rotavirus infections by DNA vaccination. J Infect Dis 1996; 174 Suppl 1:S93–7 [View Article] [PubMed]
     [Google Scholar]
  57. Davidson GP, Hogg RJ, Kirubakaran CP. Serum and intestinal immune response to Rotavirus enteritis in children. Infect Immun 1983; 40:447–452 [View Article] [PubMed]
     [Google Scholar]
  58. Hjelt K, Grauballe PC, Andersen L, Schiøtz PO, Howitz P et al. Antibody response in serum and intestine in children up to six months after a naturally acquired rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1986; 5:74–80 [View Article]
     [Google Scholar]
  59. Hjelt K, Grauballe PC, Paerregaard A, Nielsen OH, Krasilnikoff PA. Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J Med Virol 1987; 21:39–47 [View Article] [PubMed]
     [Google Scholar]
  60. Riepenhoff-Talty M, Bogger-Goren S, Li P, Carmody PJ, Barrett HJ et al. Development of serum and intestinal antibody response to Rotavirus after naturally acquired Rotavirus infection in man. J Med Virol 1981; 8:215–222 [View Article] [PubMed]
     [Google Scholar]
  61. Sonza S, Holmes IH. Coproantibody response to Rotavirus infection. Med J Aust 1980; 2:496–499 [View Article] [PubMed]
     [Google Scholar]
  62. Brandtzaeg P, Valnes K, Scott H, Rognum TO, Bjerke K et al. The human gastrointestinal secretory immune system in health and disease. Scand J Gastroenterol 1985; 20:17–38 [View Article]
     [Google Scholar]
  63. Jertborn M, Svennerholm AM, Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol 1986; 24:203–209 [View Article] [PubMed]
     [Google Scholar]
  64. Grimwood K, Lund JC, Coulson BS, Hudson IL, Bishop RF et al. Comparison of serum and mucosal antibody responses following severe acute Rotavirus gastroenteritis in young children. J Clin Microbiol 1988; 26:732–738 [View Article] [PubMed]
     [Google Scholar]
  65. Delacroix DL, Denef AM, Acosta GA, Montgomery PC, Vaerman JP. Immunoglobulins in rabbit hepatic bile: selective secretion of IgA and IgM and active plasma-to-bile transfer of polymeric IgA. Scand J Immunol 1982; 16:343–350 [View Article] [PubMed]
     [Google Scholar]
  66. Merchant AA, Groene WS, Cheng EH, Shaw RD. Murine intestinal antibody response to heterologous Rotavirus infection. J Clin Microbiol 1991; 29:1693–1701 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-79-11-2661
Loading
Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease
J. Gen. Virol. 79, 0022-1317-79-11-2661 (1998); https://doi.org/10.1099/0022-1317-79-11-2661
/content/journal/jgv/10.1099/0022-1317-79-11-2661
/content/journal/jgv/10.1099/0022-1317-79-11-2661
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error